JP2010513311A5 - - Google Patents

Download PDF

Info

Publication number
JP2010513311A5
JP2010513311A5 JP2009541599A JP2009541599A JP2010513311A5 JP 2010513311 A5 JP2010513311 A5 JP 2010513311A5 JP 2009541599 A JP2009541599 A JP 2009541599A JP 2009541599 A JP2009541599 A JP 2009541599A JP 2010513311 A5 JP2010513311 A5 JP 2010513311A5
Authority
JP
Japan
Prior art keywords
isolated polypeptide
amino acid
group
acid sequence
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009541599A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010513311A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/087477 external-priority patent/WO2008115303A2/en
Publication of JP2010513311A publication Critical patent/JP2010513311A/ja
Publication of JP2010513311A5 publication Critical patent/JP2010513311A5/ja
Pending legal-status Critical Current

Links

JP2009541599A 2006-12-13 2007-12-13 コレステロール流出の強力かつ選択的なメディエータ Pending JP2010513311A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87490906P 2006-12-13 2006-12-13
PCT/US2007/087477 WO2008115303A2 (en) 2006-12-13 2007-12-13 Potent and selective mediators of cholesterol efflux

Publications (2)

Publication Number Publication Date
JP2010513311A JP2010513311A (ja) 2010-04-30
JP2010513311A5 true JP2010513311A5 (cg-RX-API-DMAC10.html) 2011-02-03

Family

ID=39766652

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009541599A Pending JP2010513311A (ja) 2006-12-13 2007-12-13 コレステロール流出の強力かつ選択的なメディエータ

Country Status (10)

Country Link
US (1) US8987192B2 (cg-RX-API-DMAC10.html)
EP (1) EP2121746B1 (cg-RX-API-DMAC10.html)
JP (1) JP2010513311A (cg-RX-API-DMAC10.html)
CN (1) CN101675072A (cg-RX-API-DMAC10.html)
AT (1) ATE533783T1 (cg-RX-API-DMAC10.html)
AU (1) AU2007349237B2 (cg-RX-API-DMAC10.html)
CA (1) CA2672131C (cg-RX-API-DMAC10.html)
DK (1) DK2121746T3 (cg-RX-API-DMAC10.html)
ES (1) ES2377329T3 (cg-RX-API-DMAC10.html)
WO (1) WO2008115303A2 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102123722A (zh) 2008-06-18 2011-07-13 加利福尼亚大学董事会 改进的胆固醇流出的肽介质
US20110152112A1 (en) * 2009-12-23 2011-06-23 Artery Therapeutics, Inc. Diagnosis and treatment of reverse cholesterol transport deficiency-related diseases
US20130123173A1 (en) * 2010-04-28 2013-05-16 The Regents Of The University Of California Creation of oxidation-resistant hdl mimetic peptides
US10017551B2 (en) 2013-03-15 2018-07-10 The Regents Of The University Of California Peptides having reduced toxicity that stimulate cholesterol efflux
WO2016044177A1 (en) * 2014-09-17 2016-03-24 The Regents Of The University Of California Peptides having reduced toxicity that stimulate cholesterol efflux
CN112442114A (zh) * 2019-08-29 2021-03-05 渥太华Hdl药物研发公司 一种多肽及其应用
CN112511569B (zh) * 2021-02-07 2021-05-11 杭州筋斗腾云科技有限公司 网络资源访问请求的处理方法、系统及计算机设备

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055318A2 (en) 1999-03-15 2000-09-21 University Of British Columbia Abc1 polypeptide and methods and reagents for modulating cholesterol levels
ATE387459T1 (de) * 2000-04-06 2008-03-15 Kos Pharma Inc Verbindungen und methoden zur senkung des cholesterinspiegels ohne induktion von hypertriglyceridämie
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US7199102B2 (en) 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
EP1706131A4 (en) 2003-12-15 2009-08-12 Univ California THE CELLULAR CHOLESTEROL EFFLUX STIMULATING HELICULAR SYNTHETIC PEPTIDES
JP5048486B2 (ja) 2004-07-16 2012-10-17 トラスティーズ オブ タフツ カレッジ アポリポタンパク質a1の模倣物とその使用
US8541236B2 (en) 2006-12-08 2013-09-24 University Of Washington Mutant apolipoprotein A-1 polypeptide with increased resistance to oxidation and reactive carbonyls

Similar Documents

Publication Publication Date Title
RU2011101536A (ru) Усовершенствованные пептидные медиаторы оттока холестерина
RU2006107605A (ru) Пептид (варианты), пара аминокислот, снижающие интенсивность по меньшей мере одного симптома воспалительного состояния, фармацевтическая композиция (варианты), лекарственное средство и фармацевтический набор на их основе
JP5107713B2 (ja) 遅延性のエキセンディン−4化合物
JP2011525181A5 (cg-RX-API-DMAC10.html)
JP2004506693A5 (cg-RX-API-DMAC10.html)
US20080221028A1 (en) Compositions and Methods for Treating Atherosclerosis
JP2006508179A5 (cg-RX-API-DMAC10.html)
JP2008506709A5 (cg-RX-API-DMAC10.html)
CA2996975C (en) Methods for treatment of diseases
JP2020502051A5 (cg-RX-API-DMAC10.html)
SG178746A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
BRPI0717135B1 (pt) Antagonista peptídico cíclico de somastotatina e composição farmacêutica
JP2008525491A5 (cg-RX-API-DMAC10.html)
EP3565573B1 (en) Pac1 receptor agonists (maxcaps) and uses thereof
WO2015040182A2 (en) Amylin analogues
AU2016232833A1 (en) Selective Mcl-1 binding peptides
JP6549554B2 (ja) コレステロール流出を刺激する、減少した毒性を有するペプチド
Zhang et al. From erythropoietin to its peptide derivatives: smaller but stronger
JP2008502736A (ja) 高脂血症および関連疾患の治療のための複素環式誘導体
JP5421257B2 (ja) プラスミノーゲン活性化因子阻害物質1由来のペプチドおよびその使用
WO2008050133A2 (en) Inhibition of beta-amyloid aggregation
JP2017508734A (ja) 白血球動員をブロックするペプチドおよび使用方法
JP2005082489A (ja) 新規な摂食促進ペプチド、新規な成長ホルモン分泌促進ペプチド
JP2005082489A6 (ja) 新規な摂食促進ペプチド、新規な成長ホルモン分泌促進ペプチド
JP4570402B2 (ja) 中枢機能改善剤